Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy
(Q28235277)
scientific article (publication date: 26 April 2011)
scientific article (publication date: 26 April 2011)
Language:
Current Data About
Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy